Table 9 Incidence of complications in the two groups
From: Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
Complications | Study group “TXA” (n=50) | Control group “placebo” (n=50) | P |
|---|---|---|---|
Nausea | 5 (10%) | 2 (4%) | 0.433 |
Vomiting | 6 (12%) | 3 (6%) | 0.486 |
Hypotension | 2 (4%) | 1 (2%) | 0.786 |
Hypersensitivity | 0 (0%) | 0 (0%) | 1.000 |
Bradycardia | 4 (8%) | 3 (6%) | 0.839 |